1-6 of 6
Elaine Mai
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Anti-LYPD1/CD3 T-Cell-Dependent Bispecific Antibody for the Treatment of Ovarian Cancer

Amy A. Lo, Jennifer Johnston, Ji Li, Danielle Mandikian, Maria Hristopoulos, Robyn Clark, Dorothee Nickles, Wei-Ching Liang, Kathy Hötzel, Debra Dunlap, Thinh Pham, Hao Cai, Meric Ovacik, Daniel Bravo-Perez, Elaine Mai, Dionysos Slaga, Diego Ellerman, James Ziai, Klara Totpal, Genee Lee, C. Andrew Boswell, Jian Payandeh, Yan Wu, Teemu T. Junttila
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2021) 20 (4): 716–725.
https://doi.org/10.1158/1535-7163.MCT-20-0490
Published: 01 April 2021
View article titled, Anti-LYPD1/CD3 T-Cell-Dependent Bispecific Antibody for the Treatment of Ovarian Cancer
Open the PDF for Anti-LYPD1/CD3 T-Cell-Dependent Bispecific Antibody for the Treatment of Ovarian Cancer in another window
Includes: Supplementary data
Journal Articles

Nonclinical Evaluation of the Serum Pharmacodynamic Biomarkers HGF and Shed MET following Dosing with the Anti-MET Monovalent Monoclonal Antibody Onartuzumab

Elaine Mai, Zhong Zheng, Youjun Chen, Jing Peng, Christophe Severin, Ellen Filvaroff, Mally Romero, William Mallet, Surinder Kaur, Thomas Gelzleichter, Ihsan Nijem, Mark Merchant, Judy C. Young
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2014) 13 (2): 540–552.
https://doi.org/10.1158/1535-7163.MCT-13-0494
Published: 09 February 2014
View article titled, Nonclinical Evaluation of the Serum Pharmacodynamic Biomarkers HGF and Shed MET following Dosing with the Anti-MET Monovalent Monoclonal Antibody Onartuzumab
Open the PDF for Nonclinical Evaluation of the Serum Pharmacodynamic Biomarkers HGF and Shed MET following Dosing with the Anti-MET Monovalent Monoclonal Antibody Onartuzumab in another window
Includes: Supplementary data
Journal Articles

The Effect of Different Linkers on Target Cell Catabolism and Pharmacokinetics/Pharmacodynamics of Trastuzumab Maytansinoid Conjugates

Hans K. Erickson, Gail D. Lewis Phillips, Douglas D. Leipold, Carmela A. Provenzano, Elaine Mai, Holly A. Johnson, Bert Gunter, Charlene A. Audette, Manish Gupta, Jan Pinkas, Jay Tibbitts
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2012) 11 (5): 1133–1142.
https://doi.org/10.1158/1535-7163.MCT-11-0727
Published: 08 May 2012
View article titled, The Effect of Different Linkers on Target Cell Catabolism and Pharmacokinetics/Pharmacodynamics of Trastuzumab Maytansinoid Conjugates
Open the PDF for The Effect of Different Linkers on Target Cell Catabolism and Pharmacokinetics/Pharmacodynamics of Trastuzumab Maytansinoid Conjugates in another window
Includes: Supplementary data
Journal Articles

Abstract A149: The effect of linker on target cell catabolism and PK/PD of trastuzumab maytansinoid conjugates

Hans Erickson, Gail D. Lewis Phillips, Carmela Provenzano, Douglas D. Leipold, Holly Johnson, Elaine Mai, Charlene Audette, Kirsten Messick, Jan Pinkas, Manish Gupta, Jay Tibbitts
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2009) 8 (12_Supplement): A149.
https://doi.org/10.1158/1535-7163.TARG-09-A149
Published: 10 December 2009
View article titled, Abstract A149: The effect of linker on target cell catabolism and PK/PD of trastuzumab maytansinoid conjugates
Journal Articles

HGF and cMet extracellular domain levels in serum versus plasma from mice, monkeys, and humans

Elaine Mai, Mark Merchant, Wai Lee Wong, Judy Young
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2007) 6 (11_Supplement): C154.
Published: 01 November 2007
View article titled, HGF and cMet extracellular domain levels in serum <em>versus </em>plasma from mice, monkeys, and humans
Journal Articles

Development of a pharmacokinetic model examining trastuzumab-MCC-DM1, MCC-DM1 and DM1 in normal rats

Douglas Leipold, Helen Moore, Shasha Jumbe, Jakub Baudys, Ola Saad, Elaine Mai, Wai Lee Wong, Jay Tibbitts
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2007) 6 (11_Supplement): C155.
Published: 01 November 2007
View article titled, Development of a pharmacokinetic model examining trastuzumab-MCC-DM1, MCC-DM1 and DM1 in normal rats